Evidence map›Paper›PMID 42510031›Full record

ReviewDiagnostics (Basel, Switzerland)2026

Advances in the Interpretation of the Electrocardiogram by Artificial Intelligence.

S Suave Lobodzinski, Ryszard Piotrowicz

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S Suave LobodzinskiSchool of Medicine, University of California, Los Angeles, CA 90095, USA.
Ryszard PiotrowiczNational Institute of Cardiology, 04-628 Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The electrocardiogram (ECG) is essential for cardiovascular diagnosis but limited by inter-observer variability, low sensitivity for subclinical disease, and labor-intensive telemonitoring analysis. Artificial intelligence (AI), particularly deep learning, addresses these constraints by extracting high-dimensional patterns that correlate with arrhythmias, structural abnormalities, and systemic conditions. This integrative review synthesizes recent advances in AI-enabled ECG, covering technical foundations-including foundation models and validation strategies-and clinical applications, such as arrhythmia detection, structural heart disease identification, and digital biomarker derivation. We discuss emerging trends like self-supervised learning, multimodal integration, generative models, and explainability techniques. Furthermore, we tackle critical challenges regarding generalizability, algorithmic bias, privacy, and regulatory systems. Finally, we outline research priorities, including curated open datasets, and deployment in resource-constrained settings. With stringent validation, transparent governance, and human-centered design, AI-ECG has the potential to enhance cardiovascular diagnostics and clinical outcomes across a variety of healthcare settings.

Indexed as

AI-ECGarrhythmia detectionartificial intelligencecardiovascular diagnosticsclinical decision supportdeep learningdigital biomarkerselectrocardiography

Identifiers

PMID42510031
PMCPMC13408101

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.